Forest Beats Final Cases In Celexa, Lexapro MDL
Forest Laboratories Inc. prevailed on Monday against claims by a health and benefit fund and a pair of mothers that it fraudulently promoted Celexa and Lexapro for pediatric depression, putting long-running...To view the full article, register now.
Already a subscriber? Click here to view full article